Indraprastha Apollo Hospital New Delhi organized an interaction program in Kathmandu to inform the Nepali mass about the complexities of lung and heart disease.

 Senior doctors MS Kanwar, Vanita Arora, and Mukesh Goel briefed journalists about the advanced treatment modalities available in the hospital. They provided details about the lung and heart transplant services of the hospital.  

Speaking at the interaction, Dr. Kanwar said: “The lung transplant is not just a surgery but a process starting with extensive pre-lung transplant work up and optimal stabilization of the patients of end-stage various diseases.” He said many international patients from other countries are currently under our treatment at Apollo hospital or waiting to be stabilized and transferred for the lung transplant.

Dr. Arora said that in patients with reduced heart function, the cause of high mortality is either heart pump failure or sudden cardiac arrest. She said, “After careful screening patients can be saved by implanting Cardiac Resynchronization Therapy device or automatic implantable defibrillator device.”

Dr. Goel said living with chronic lung failure is very painful and taxing for the patient and family. “Lung transplant as a treatment modality can improve the quality of life for a patient suffering from end-stage of lung disease.”  

In the interaction program, they informed about the tentative cost, procedures, and other aspects of lung and heart transplants in New Delhi. They underlined the need of creating awareness in Nepali society about the transplant. There is not much awareness in Nepal about the lungs and heart transplants.